Primary Outcomes of Patients with Chronic Angle-Closure Glaucoma Treated with Combined Phacoemulsification, Viscogoniosynechialysis, and Endocyclophotocoagulation

Joint Authors

Mejías Smith, Josefina A.
Agudelo Arbelaez, Natalia
Rubio Lastra, Bárbara
Izquierdo Villavicencio, Juan Carlos
Ramirez, Imelda
Quezada, Fabiola
Ponte, Maria Corina
Cañola, Laura

Source

Journal of Ophthalmology

Issue

Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-5, 5 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2019-06-13

Country of Publication

Egypt

No. of Pages

5

Main Subjects

Medicine

Abstract EN

Purpose/Objective.

To evaluate the effectiveness of combined phacoemulsification, viscogoniosynechialysis (VGSL), and endocyclophotocoagulation (ECP) in patients with moderate chronic angle-closure glaucoma (CACG) with peripheral anterior synechia (PAS) ≥90 not controlled with glaucoma medications and previous iridotomy yag laser.

Materials and Methods.

We retrospectively reviewed records from patients with cataract and uncontrolled chronic angle-closure glaucoma despite maximal tolerated medical therapy and iridotomy yag laser who received combined treatment with phacoemulsification with posterior capsular lens implantation, VGSL, and ECP 360°.

We evaluated intraocular pressure (IOP), glaucoma medications, and best corrected visual acuity (BCVA) preoperatively and during follow-up.Results.

A total of 29 eyes from 22 patients received surgical intervention.

Mean follow-up was 6 months.

Mean preoperative IOP was 18.2 mmHg, and postoperatively, IOP was 13.5, 12.2, and 12.8 mmHg at 1, 3, and 6 months, respectively.

Complete success was 37.9%, and relative success was 72.4%.

Mean BCVA was 0.4 logMAR preoperative and 0.3 logMAR 6 months after surgery.

Glaucoma medication fell significantly from 2.34 ± 1.66 preoperatively to 1.31 ± 2.6 postoperatively p<0.001.

Overall, 44.8% of the patients did not require glaucoma medications at 6 months.

There were no visual significant complications.

Conclusion.

Combined treatment with phacoemulsification with posterior capsular lens implantation, VGSL, and ECP is effective and safe in reducing IOP and number of glaucoma medications with stable BCVA at 6 months.

American Psychological Association (APA)

Izquierdo Villavicencio, Juan Carlos& Agudelo Arbelaez, Natalia& Rubio Lastra, Bárbara& Ramirez, Imelda& Quezada, Fabiola& Ponte, Maria Corina…[et al.]. 2019. Primary Outcomes of Patients with Chronic Angle-Closure Glaucoma Treated with Combined Phacoemulsification, Viscogoniosynechialysis, and Endocyclophotocoagulation. Journal of Ophthalmology،Vol. 2019, no. 2019, pp.1-5.
https://search.emarefa.net/detail/BIM-1186335

Modern Language Association (MLA)

Izquierdo Villavicencio, Juan Carlos…[et al.]. Primary Outcomes of Patients with Chronic Angle-Closure Glaucoma Treated with Combined Phacoemulsification, Viscogoniosynechialysis, and Endocyclophotocoagulation. Journal of Ophthalmology No. 2019 (2019), pp.1-5.
https://search.emarefa.net/detail/BIM-1186335

American Medical Association (AMA)

Izquierdo Villavicencio, Juan Carlos& Agudelo Arbelaez, Natalia& Rubio Lastra, Bárbara& Ramirez, Imelda& Quezada, Fabiola& Ponte, Maria Corina…[et al.]. Primary Outcomes of Patients with Chronic Angle-Closure Glaucoma Treated with Combined Phacoemulsification, Viscogoniosynechialysis, and Endocyclophotocoagulation. Journal of Ophthalmology. 2019. Vol. 2019, no. 2019, pp.1-5.
https://search.emarefa.net/detail/BIM-1186335

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1186335